文献速递胸部CT

胸部CT检出的间质性肺异常的患病率与进展率:系统综述与荟萃分析

Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2024-07-19

该系统综述与荟萃分析纳入19项研究(241,541例)估计间质性肺异常(ILA)的合并患病率为9.7%(95%CI 6.1-13.9%),10项研究(1317例)的合并进展率为47.1%(95%CI 29.1-65.5%);随访≥4.5年组进展率64.2%高于<4.5年组31.0%(p=0.009),纤维化型ILA与影像学进展风险升高相关(合并OR 5.55,95%CI 1.95-15.82)。

要点

  • 胸部CT上ILA的合并患病率约9.7%,一般人群6.8%、肺癌高危人群7.1%。
  • ILA合并影像学进展率47.1%,随访≥4.5年者进展率高于<4.5年者。
  • 纤维化型ILA与影像学进展概率升高显著相关(合并OR 5.55)。

核心结论

  • ILA患病率约9.7%,约半数患者出现影像学进展,较长随访时间和纤维化型ILA与更高的进展率相关。

研究设计与样本

  • 系统综述与荟萃分析,检索EMBASE和PubMed截至2023年5月10日符合纳入标准的研究,采用随机效应模型估计合并患病率、ILA进展率及基于影像学亚型的进展OR,并以非随机研究偏倚风险评估工具评价纳入研究质量。

诊断标准与关键数值

  • 19项研究(241,541例)合并ILA患病率9.7%(95%CI 6.1-13.9%);一般人群(6项研究)6.8%(95%CI 3.1-11.6%),肺癌高危人群(6项研究)7.1%(95%CI 2.2-14.4%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To estimate the pooled prevalence and progression rate of ILAs and identify the risk factors for radiological progression.

MATERIALS AND METHODS: An EMBASE and PubMed search was undertaken, identifying all studies meeting the inclusion criteria performed before May 10, 2023. Random effect models were used to estimate pooled prevalence, ILA progression rates, and odds ratio for radiological progression based on radiological subtype. Subgroup analyses were performed to compare the general and high-risk populations for lung cancer. The quality of the included studies was evaluated using the risk of bias assessment tool for non-randomized studies.

RESULTS: We analyzed 19 studies (241,541 patients) and 10 studies (1317 patients) for the pooled prevalence and progression rate of ILA, respectively. The pooled ILA prevalence was 9.7% (95% CI, 6.1-13.9%). The pooled prevalence was 6.8% (95% CI, 3.1-11.6%) and 7.1% (95% CI, 2.2-14.4%) in the general (six studies) and high-risk population for lung cancer (six studies), respectively. The pooled progression rate was 47.1% (95% CI, 29.1-65.5%). The pooled progression rate was 64.2% (95% CI, 45.0-81.2%, five studies) and 31.0% (95% CI, 8.2-60.5%, five studies) for longer (≥ 4.5 years) and shorter follow-up periods (< 4.5 years), respectively (p = 0.009). Fibrotic ILAs were significantly associated with a higher progression probability (combined OR, 5.55; 95% CI, 1.95-15.82).

CONCLUSIONS: The prevalence of ILAs was approximately 9.7%. Approximately half of the patients exhibited radiological progression, with the rate increasing over a longer follow-up period. Fibrotic ILA was a significant risk factor for radiological progression.

CLINICAL RELEVANCE STATEMENT: The prevalence of interstitial lung abnormalities (ILAs) is approximately 9.7%, with about half exhibiting progression; a longer follow-up duration and fibrotic ILAs are associated with a higher progression rate.

KEY POINTS: ILAs are increasingly recognized as important, but few population data are available. ILAs exhibited a pooled prevalence of 9.7% with a progression rate of 47.1%. Fibrotic ILAs were associated with increased progression likelihood.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Hwang J, You S, Lee YJ, et al. Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 39026064. doi:10.1007/s00330-024-10952-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。